VSV-tumor selective replication and protein translation

Oncogene

Volumn 24, Issue 52, 2005, Pages 7710-7719

  Barber, Glen N ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; ELONGATION FACTOR 2; INITIATION FACTOR 4F; JANUS KINASE 1; JANUS KINASE 2; MAJOR HISTOCOMPATIBILITY ANTIGEN; RAPAMYCIN; STAT PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; VESICULAR STOMATATIS VIRUS VACCINE; VIRUS VECTOR;

5' UNTRANSLATED REGION; CANCER THERAPY; CPG ISLAND; CYTOTOXIC T LYMPHOCYTE; GENE OVEREXPRESSION; HELA CELL; IMMUNE RESPONSE; IMMUNOMODULATION; INNATE IMMUNITY; INTERFERON PRODUCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALIGNANT TRANSFORMATION; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN PHOSPHORYLATION; PROTEIN SECONDARY STRUCTURE; REPORTER GENE; REVIEW; RNA TRANSLATION; SEROPREVALENCE; SUICIDE GENE THERAPY; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION INITIATION; VESICULAR STOMATITIS VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRUS MORPHOLOGY; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS TRANSCRIPTION; VIRUS TRANSFORMATION;

IMMUNITY, NATURAL; INTERFERONS; MUTATION; NEOPLASMS; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; PROTEIN BIOSYNTHESIS; VESICULAR STOMATITIS-INDIANA VIRUS; VIRUS REPLICATION;

VESICULAR STOMATITIS VIRUS;

EID: 27944432605     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209042     Document Type: Review

References (92)

1. Abbott CM and Proud CG. (2004). Trends Biochem. Sci., 29, 25-31.
2. Abraham N, Stojdl DF, Duncan PI, Methot N, Ishii T, Dube M, Vanderhyden BC, Atkins HL, Gray DA, McBurney MW, Koromilas AE, Brown EG, Sonenberg N and Bell JC. (1999). J. Biol. Chem., 274, 5953-5962.
3. Akira S and Takeda K. (2004). Nat. Rev. Immunol., 4, 499-511.
4. Balachandran S and Barber GN. (2000). IUBMB Life, 50, 135-138.
5. Balachandran S and Barber GN. (2004). Cancer Cell, 5, 51-65.
6. Balachandran S, Porosnicu M and Barber GN. (2001). J. Virol., 75, 3474-3479.
7. Balachandran S, Roberts PC, Brown LE, Truong H, Pattnaik AK, Archer DR and Barber GN. (2000a). Immunity, 13, 129-141.
8. Balachandran S, Roberts PC, Kipperman T, Bhalla KN, Compans RW, Archer DR and Barber GN. (2000b). J. Virol., 74, 1513-1523.
9. Balachandran S, Thomas E and Barber GN. (2004). Nature, 432, 401-405.
10. Ball LA, Pringle CR, Flanagan B, Perepelitsa VP and Wertz GW. (1999). J. Virol., 73, 4705-4712.
11. Banchereau J and Palucka AK. (2005). Nat. Rev. Immunol., 5, 296-306.
12. Barber GN. (2000). Semin. Cancer Biol., 10, 103-111.
13. Barber GN. (2004). Viral Immunol., 17, 516-527.
14. Bergman I, Whitaker-Dowling P, Gao Y, Griffin JA and Watkins SC. (2003). Virology, 316, 337-347.
15. Bergmann M, Romirer I, Sachet M, Fleischhacker R, Garcia-Sastre A, Palese P, Wolff K, Pehamberger H, Jakesz R and Muster T. (2001). Cancer Res., 61, 8188-8193.
16. Bi Z, Barna M, Komatsu T and Reiss CS. (1995). J. Virol., 69, 6466-6472.
17. Biederer C, Ries S, Brandts CH and McCormick F. (2002). J. Mol. Med., 80, 163-175.
18. Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M, Ng L, Nye JA, Sampson-Johannes A, Fattaey A and McCormick F. (1996). Science, 274, 373-376.
19. Bjornsti MA and Houghton PJ. (2004). Cancer Cell, 5, 519-523.
20. Boehme KW and Compton T. (2004). J. Virol., 78, 7867-7873.
21. Carneiro FA, Bianconi ML, Weissmuller G, Stauffer F and Da Poian AT. (2002). J. Virol., 76, 3756-3764.
22. Chiocca EA. (2002). Nat. Rev. Cancer, 2, 938-950.
23. Clemens MJ. (2001). Prog. Mol. Subcell Biol., 27, 57-89.
24. Coffey MC, Strong JE, Forsyth PA and Lee PW. (1998). Science, 282, 1332-1334.
25. Connor JH and Lyles DS. (2002). J. Virol., 76, 10177-10187.
26. Connor JH and Lyles DS. (2005). J. Biol. Chem., 280, 13512-13519.
27. de Mattos C, de Mattos CC and Rupprecht CE. (2001). Rhabdoviridae: The Viruses and their Replication 4th edn. Lippincott Williams and Wilkins: New York.
28. Desforges M, Charron J, Berard S, Beausoleil S, Stojdl DF, Despars G, Laverdiere B, Bell JC, Talbot PJ, Stanners CP and Poliquin L. (2001). Virus Res., 76, 87-102.
29. Donze O, Jagus R, Koromilas AE, Hershey JW and Sonenberg N. (1995). EMBO J., 14, 3828-3834.
30. Ebert O, Shinozaki K, Kournioti C, Park MS, Garcia-Sastre A and Woo SL. (2004). Cancer Res., 64, 3265-3270.
31. Enninga J, Levy DE, Blobel G and Fontoura BM. (2002). Science, 295, 1523-1525.
32. Faria PA, Chakraborty P, Levay A, Barber GN, Ezelle HJ, Enninga J, Arana C, van Deursen J and Fontoura BM. (2005). Mol. Cell, 17, 93-102.
33. Fernandez M, Porosnicu M, Markovic D and Barber GN. (2002). J. Virol., 76, 895-904.
34. Gomez E, Mohammad SS and Pavitt GD. (2002). EMBO J., 21, 5292-5301.
35. Hammon WM, Yohn DS, Casto BC and Atchison RW. (1963). J. Natl. Cancer Inst., 31, 329-345.
36. Hay N and Sonenberg N. (2004). Genes Dev., 18, 1926-1945.
37. Hershey JW. (1991). Annu. Rev. Biochem., 60, 717-755.
38. Hii SI, Hardy L, Crough T, Payne EJ, Grimmett K, Gill D and McMillan NA. (2004). Int. J. Cancer, 109, 329-335.
39. Holland EC, Sonenberg N, Pandolfi PP and Thomas G. (2004). Oncogene, 23, 3138-3144.
40. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N and Taniguchi T. (2005). Nature, 434, 772-777.
41. Kang DC, Gopalkrishnan RV, Wu Q, Jankowsky E, Pyle AM and Fisher PB. (2002). Proc. Natl. Acad. Sci. USA, 99, 637-642.
42. Kapp LD and Lorsch JR. (2004). Annu. Rev. Biochem., 73, 657-704.
43. Kim SH, Gunnery S, Choe JK and Mathews MB. (2002). Oncogene, 21, 8741-8748.
44. Kimball SR. (2001). Prog. Mol. Subcell Biol., 26, 155-184.
45. Kimball SR, Heinzinger NK, Horetsky RL and Jefferson LS. (1998). J. Biol. Chem., 273, 3039-3044.
46. Koromilas AE, Roy S, Barber GN, Katze MG and Sonenberg N. (1992). Science, 257, 1685-1689.
47. Lamberti A, Caraglia M, Longo O, Marra M, Abbruzzese A and Arcari P. (2004). Amino Acids, 26, 443-448.
48. Leegwater PA, Vermeulen G, Konst AA, Naidu S, Mulders J, Visser A, Kersbergen P, Mobach D, Fonds D, van Berkel CG, Lemmers RJ, Frants RR, Oudejans CB, Schutgens RB, Pronk JC and van der Knaap MS. (2001). Nat. Genet., 29, 383-388.
49. Lengyel P. (1993). Proc. Natl. Acad. Sci. USA, 90, 5893-5895.
50. Lodish HF and Porter M. (1980). J. Virol., 36, 719-733.
51. Malmgaard L. (2004). J. Interferon. Cytokine Res., 24, 439-454.
52. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenland AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M and Schreiber RD. (1996). Cell, 84, 431-442.
53. Merrick WC. (2004). Gene, 332, 1-11.
54. Meurs E, Chong K, Galabru J, Thomas NS, Kerr IM, Williams BR and Hovanessian AG. (1990). Cell, 62, 379-390.
55. Meurs EF, Galabru J, Barber GN, Katze MG and Hovanessian AG. (1993). Proc. Natl. Acad. Sci. USA, 90, 232-236.
56. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM and Aguet M. (1994). Science, 264, 1918-1921.
57. Obuchi M, Fernandez M and Barber GN. (2003). J. Virol., 77, 8843-8856.
58. Ochsenbein AF, Fehr T, Lutz C, Suter M, Brombacher F, Hengartner H and Zinkernagel RM. (1999). Science, 286, 2156-2159.
59. Pandolfi PP. (2004). Oncogene, 23, 3134-3137.
60. Pasare C and Medzhitov R. (2003). Curr. Opin. Immunol., 15, 677-682.
61. Pavitt GD, Ramaiah KV, Kimball SR and Hinnebusch AG. (1998). Genes Dev., 12, 514-526.
62. Pavitt GD, Yang W and Hinnebusch AG. (1997). Mol. Cell. Biol., 17, 1298-1313.
63. Petersen JM, Her LS, Varvel V, Lund E and Dahlberg JE. (2000). Mol. Cell. Biol., 20, 8590-8601.
64. Pitha PM. (2000). Semin. Cancer Biol., 10, 69-72.
65. Plakhov IV, Arlund EE, Aoki C and Reiss CS. (1995). Virology, 209, 257-262.
66. Porosnicu M, Mian A and Barber GN. (2003). Cancer Res., 63, 8366-8376.
67. Proud CG. (2001). Prog. Mol. Subcell Biol., 26, 95-114.
68. Richter JD and Sonenberg N. (2005). Nature, 433, 477-480.
69. Roberts A, Buonocore L, Price R, Forman J and Rose JK. (1999). J. Virol., 73, 3723-3732.
70. Roberts A, Kretzschmar E, Perkins AS, Forman J, Price R, Buonocore L, Kawaoka Y and Rose JK. (1998). J. Virol., 72, 4704-4711.
71. Ron D. (2002). J. Clin. Invest., 110, 1383-1388.
72. Rose JK and Whitt MA. (2001). Rhabdoviridae: The Viruses and their Replication 4th edn. Lippincott Williams and Wilkins: New York.
73. Rose NF, Roberts A, Buonocore L and Rose JK. (2000). J. Virol., 74, 10903-10910.
74. Ruggero D and Pandolfi PP. (2003). Nat. Rev. Cancer, 3, 179-192.
75. Salomoni P and Pandolfi PP. (2002). Cell, 108, 165-170.
76. Schnell MJ, Buonocore L, Whitt MA and Rose JK. (1996). J. Virol., 70, 2318-2323.
77. Schnell MJ, Johnson JE, Buonocore L and Rose JK. (1997). Cell, 90, 849-857.
78. Sherr CJ. (2001). Nat. Rev. Mol. Cell Biol., 2, 731-737.
79. Stark GR, Kerr IM, Williams BR, Silverman RH and Schreiber RD. (1998). Annu. Rev. Biochem., 67, 227-264.
80. Stojdl DF, Lichty B, Knowles S, Marius R, Atkins H, Sonenberg N and Bell JC. (2000). Nat. Med., 6, 821-825.
81. Stojdl DF, Lichty BD, tenOever BR, Paterson JM, Power AT, Knowles S, Marius R, Reynard J, Poliquin L, Atkins H, Brown EG, Durbin RK, Durbin JE, Hiscott J and Bell JC. (2003). Cancer Cell, 4, 263-275.
82. Tanaka N and Taniguchi T. (2000). Semin. Cancer Biol., 10, 73-81.
83. Thomsen AR, Nansen A, Andersen C, Johansen J, Marker O and Christensen JP. (1997). Int. Immunol., 9, 1757-1766.
84. Tough DF. (2004). Leuk. Lymphoma, 45, 257-264.
85. van den Pol AN, Dalton KP and Rose JK. (2002). J. Virol., 76, 1309-1327.
86. Varghese S and Rabkin SD. (2002). Cancer Gene Ther., 9, 967-978.
87. von Kobbe C, van Deursen JM, Rodrigues JP, Sitterlin D, Bachi A, Wu X, Wilm M, Carmo-Fonseca M and Izaurralde E. (2000). Mol. Cell., 6, 1243-1252.
88. Wang S, Rosenwald IB, Hutzler MJ, Pihan GA, Savas L, Chen JJ and Woda BA. (1999). Am. J. Pathol., 155, 247-255.
89. Wang X, Paulin FE, Campbell LE, Gomez E, O'Brien K, Morrice N and Proud CG. (2001). EMBO J., 20, 4349-4359.
90. Williams DD, Price NT, Loughlin AJ and Proud CG. (2001). J. Biol. Chem., 276, 24697-24703.
91. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S and Fujita T. (2004). Nat. Immunol., 5, 730-737.
92. Zhang K and Kaufman RJ. (2004). J. Biol. Chem., 279, 25935-25938.